Should a patient with locally advanced prostate cancer, Gleason score of 8, and high-risk features, who has shown a significant response to Androgen Deprivation Therapy (ADT) with a decrease in Prostate-Specific Antigen (PSA) levels, receive extended ADT for 1.5 to 2 years after a single dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 17, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the next steps for a male with a history of Gleason 6 prostate cancer, treated with radiation therapy, now presenting with a biochemical recurrence as indicated by an elevated Prostate-Specific Antigen (PSA) level, without evidence of metastatic disease on PET scan?

What is the next step in management for an elderly patient with metastatic prostate cancer on androgen deprivation therapy (ADT) with rising Prostate-Specific Antigen (PSA) levels?

What are the treatment options for a 67-year-old patient with Gleason 7 (4+3) prostate cancer, ISUP (International Society of Urological Pathology) grade 3?

What is the next plan for a patient with Gleason 6 prostate cancer, status post radiation therapy, with a rising Prostate-Specific Antigen (PSA) from 0.4 to 7?

What is the recommended management approach for a patient with locally advanced prostate cancer and a Gleason score of 4+3?

What are the treatment options for an elderly patient with aortic valve thickening (aortic stenosis) and a history of cardiovascular disease?

What is the appropriate diagnosis and treatment for a patient with symptoms such as numbness, tingling, or weakness in the ring and little fingers, as well as pain or discomfort in the elbow or wrist, who may have been misdiagnosed?

How do postoperative adhesions cause ileocecal (small intestine and colon) intussusception in a patient with a history of abdominal surgery?

What is the best management approach for a patient with a large hepatocellular carcinoma (HCC) and elevated bilirubin levels potentially due to tumor obstruction, with a Child-Pugh score of B7?

What are the guidelines for safely closing a hemodialysis session in patients with end-stage renal disease (ESRD) or acute kidney injury (AKI) to prevent complications such as hypotension?

Does the brain have backup pathways to produce neurosteroids in a middle-aged to older male patient with a history of Benign Prostatic Hyperplasia (BPH) or androgenetic alopecia when 5-alpha-reductase (5AR) is inhibited by dutasteride (generic name: dutasteride)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.